NPM1 and acute myeloid leukemia: Intriguingly, in a survival analysis of 25 patients affected with NPM1-mutated AML, a better overall survival (OS) was observed in patients with NPM1-mutated-specific T-cell responses, suggesting that immunity against the mutated region of NPM1 may potentially contribute to the favorable clinical outcome of NPM1-mutated AML patients [9].